RD

Rajesh Dinkar Sawant

Director Whole-Time Director DIN 00380168
DIN 00380168 First appointment Dec 2005 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2005
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Dinkar Sawant

Data last updated:

Rajesh Dinkar Sawant was a Whole-Time Director at Medispray Laboratories Private Limited (2005–2021) and Director at Medule Pharma Private Limited (from 2005). The companies operate in Pharma.

DIN 00380168
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 01 Dec 2005
Oldest Company Age 26 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director01 Dec 20051992₹444 Cr (FY 2025)Active
Medule Pharma Private Limited U24230MH2000PTC125851
Director01 Dec 20052000Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medule Pharma Private Limited
Medispray Laboratories Private Limited
Premium access

Shareholding and investment profile for Rajesh Dinkar Sawant

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Dinkar Sawant

Rajesh Dinkar Sawant was first appointed on 01 Dec 2005 as Whole-Time Director at Medispray Laboratories Private Limited.

Rajesh Dinkar Sawant held 2 earlier board appointments: Medispray Laboratories Private Limited (Whole-Time Director, 01 Dec 2005 to 26 Mar 2021); Medule Pharma Private Limited (Director, from 01 Dec 2005).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available